Production (Stage)
Lisata Therapeutics, Inc.
LSTA
$2.69
$0.041.51%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.31M | -19.99M | -20.74M | -21.07M | -20.05M |
| Total Depreciation and Amortization | 171.00K | 174.00K | 180.00K | 185.00K | 187.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.42M | 1.33M | 994.00K | 752.00K | 972.00K |
| Change in Net Operating Assets | -9.00K | -873.00K | 669.00K | 172.00K | 32.00K |
| Cash from Operations | -17.73M | -19.36M | -18.90M | -19.96M | -18.86M |
| Capital Expenditure | -28.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 16.26M | 13.23M | 6.13M | 24.69M | 12.25M |
| Cash from Investing | 16.23M | 13.23M | 6.13M | 24.69M | 12.25M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 288.00K | 68.00K | 56.00K | 56.00K | 476.00K |
| Repurchase of Common Stock | -375.00K | -274.00K | -142.00K | -148.00K | -148.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -87.00K | -206.00K | -86.00K | -92.00K | 328.00K |
| Foreign Exchange rate Adjustments | 2.00K | -55.00K | -66.00K | -30.00K | -64.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.59M | -6.38M | -12.92M | 4.60M | -6.35M |